|
|
|
|
| LEADER |
01577nma a2200265 u 4500 |
| 001 |
EB001833081 |
| 003 |
EBX01000000000000000999527 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
180616 ||| eng |
| 100 |
1 |
|
|a Paris, Valérie
|
| 245 |
0 |
0 |
|a Pharmaceutical Pricing and Reimbursement Policies in Canada
|h Elektronische Ressource
|c Valérie, Paris and Elizabeth, Docteur
|
| 260 |
|
|
|a Paris
|b OECD Publishing
|c 2006
|
| 300 |
|
|
|a 90 p.
|c 21 x 29.7cm
|
| 653 |
|
|
|a Social Issues/Migration/Health
|
| 653 |
|
|
|a Canada
|
| 700 |
1 |
|
|a Docteur, Elizabeth
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b OECD
|a OECD Books and Papers
|
| 490 |
0 |
|
|a OECD Health Working Papers
|
| 024 |
8 |
|
|a /10.1787/346071162287
|
| 856 |
4 |
0 |
|a oecd-ilibrary.org
|u https://doi.org/10.1787/346071162287
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 304
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada's achievements in meeting a range of objectives relating to the pharmaceutical policy. The federal government regulates prices of patented pharmaceutical products with the objective of protecting consumers against excessive prices. Regulation has very likely been responsible for bringing Canada's prices for patented medicines roughly in line with European comparators. Prices of generic products, which are not regulated, are relatively high although high..
|